127 related articles for article (PubMed ID: 9260793)
1. Iron overload in patients with chronic viral hepatitis: how common is it?
Riggio O; Montagnese F; Fiore P; Folino S; Giambartolomei S; Gandin C; Merli M; Quinti I; Violante N; Caroli S; Senofonte O; Capocaccia L
Am J Gastroenterol; 1997 Aug; 92(8):1298-1301. PubMed ID: 9260793
[TBL] [Abstract][Full Text] [Related]
2. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
[TBL] [Abstract][Full Text] [Related]
3. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study].
Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J
Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321
[TBL] [Abstract][Full Text] [Related]
4. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
5. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
7. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
8. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
[TBL] [Abstract][Full Text] [Related]
9. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B.
Bayraktar Y; Saglam F; Temizer A; Uzunalimodlu B; van Thiel DH
Hepatogastroenterology; 1998; 45(24):2322-7. PubMed ID: 9951916
[TBL] [Abstract][Full Text] [Related]
10. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
11. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy.
Tsai NC; Zuckerman E; Han SH; Goad K; Redeker AG; Fong TL
Am J Gastroenterol; 1997 Oct; 92(10):1831-4. PubMed ID: 9382046
[TBL] [Abstract][Full Text] [Related]
12. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
[TBL] [Abstract][Full Text] [Related]
13. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
[TBL] [Abstract][Full Text] [Related]
14. Decrease in serum ferritin level in a patient with HCV hepatitis and liver hemosiderosis by interferon-alpha.
Kawada E; Shinonome S; Tamura J; Murakami H
J Med; 1994; 25(6):388-92. PubMed ID: 7769377
[TBL] [Abstract][Full Text] [Related]
15. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
16. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
[TBL] [Abstract][Full Text] [Related]
17. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
[TBL] [Abstract][Full Text] [Related]
18. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
[TBL] [Abstract][Full Text] [Related]
19. [Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment].
Bolewska B; Wojtacha A; Juszczyk J; Przedwojewski M
Pol Merkur Lekarski; 2005 May; 18(107):552-5. PubMed ID: 16161954
[TBL] [Abstract][Full Text] [Related]
20. [Serologic response against hepatitis C virus as a predictive factor to the treatment with interferon].
Garrido A; Lepe JA; Guerrero FJ; Palomo S
Enferm Infecc Microbiol Clin; 2000 Dec; 18(10):512-5. PubMed ID: 11198002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
